Studies on Diabetic and Pre Diabetic Vascular Disease and the Effect of Selected Therapeutic Modalities on Associated Vasculopathy.
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2009
At a glance
- Drugs Ramipril (Primary) ; Rosiglitazone (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 02 Aug 2007 New trial record.
- 01 Aug 2007 Results have been published